Karyopharm Therapeutics KPTI Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue$37.9MMiss by $1.6M
EPS-$4.32Miss by $0.52
Revenue estimate$39.6M
EPS estimate-$3.80
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$33.6M
EPS estimate-$1.31
Versus estimates
Revenue
Diluted EPS
Ask the moment Karyopharm Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Karyopharm Therapeutics report Q2 2025 earnings?
- Karyopharm Therapeutics (KPTI) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Karyopharm Therapeutics's Q2 2025 revenue and EPS?
- Karyopharm Therapeutics reported revenue of $37.9M and eps of $-4.32 for Q2 2025.
- Did Karyopharm Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $39.6M by $1.6M. EPS missed the consensus estimate of $-3.80 by $0.52.
- How did Karyopharm Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 11.4% from $42.8M a year earlier and eps declined 44.0% from $-3.00.
- Where can I find Karyopharm Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-106238) directly on SEC EDGAR. The filing index links above go to sec.gov.